Major drug trial tests Long-Term safety for schizophrenia treatment

NCT ID NCT07114874

Recruiting now Disease control Sponsor: Neurocrine Biosciences Source: ClinicalTrials.gov ↗

Summary

This study is testing the long-term safety of an investigational medication called NBI-1117568 for adults with schizophrenia. The trial will enroll 800 participants worldwide to monitor side effects and how well people tolerate the drug over an extended period. This is an open-label study, meaning all participants will receive the active medication rather than a placebo.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Neurocrine Clincial Site
RECRUITING

Staten Island, New York, 10314, United States
Neurocrine Clinical Site
RECRUITING

Little Rock, Arkansas, 72211, United States
Neurocrine Clinical Site
RECRUITING

Culver City, California, 90230, United States
Neurocrine Clinical Site
RECRUITING

Garden Grove, California, 92845, United States
Neurocrine Clinical Site
RECRUITING

Pico Rivera, California, 90660, United States
Neurocrine Clinical Site
RECRUITING

Riverside, California, 92506, United States
Neurocrine Clinical Site
RECRUITING

San Diego, California, 92123, United States
Neurocrine Clinical Site
RECRUITING

Sherman, California, 91403, United States
Neurocrine Clinical Site
RECRUITING

Torrance, California, 90504, United States
Neurocrine Clinical Site
RECRUITING

Hollywood, Florida, 33024, United States
Neurocrine Clinical Site
RECRUITING

Miami Lakes, Florida, 33016, United States
Neurocrine Clinical Site
RECRUITING

Atlanta, Georgia, 30328, United States
Neurocrine Clinical Site
RECRUITING

Atlanta, Georgia, 30331, United States
Neurocrine Clinical Site
RECRUITING

Decatur, Georgia, 30030, United States
Neurocrine Clinical Site
RECRUITING

Chicago, Illinois, 60640, United States
Neurocrine Clinical Site
RECRUITING

Gaithersburg, Maryland, 20877, United States
Neurocrine Clinical Site
RECRUITING

Watertown, Massachusetts, 02472, United States
Neurocrine Clinical Site
RECRUITING

St Louis, Missouri, 63141, United States
Neurocrine Clinical Site
RECRUITING

Marlton, New Jersey, 08053, United States
Neurocrine Clinical Site
RECRUITING

Austin, Texas, 78754, United States
Neurocrine Clinical Sites
RECRUITING

Peachtree Corners, Georgia, 30071, United States
Neurocrine Clinical Sites
RECRUITING

The Bronx, New York, 10461, United States
Neurocrine Clinical Sites
RECRUITING

North Canton, Ohio, 44720, United States
Neurocrine Clinical Sites
RECRUITING

Orem, Utah, 84058, United States

Conditions

Explore the condition pages connected to this study.

SCHIZOPHRENIA